138 related articles for article (PubMed ID: 30819034)
1. Evaluation of Intervention Impact on Health Inequality for Resource Allocation.
Griffin S; Love-Koh J; Pennington B; Owen L
Med Decis Making; 2019 Apr; 39(3):171-182. PubMed ID: 30819034
[TBL] [Abstract][Full Text] [Related]
2. Aggregate Distributional Cost-Effectiveness Analysis of Health Technologies.
Love-Koh J; Cookson R; Gutacker N; Patton T; Griffin S
Value Health; 2019 May; 22(5):518-526. PubMed ID: 31104729
[TBL] [Abstract][Full Text] [Related]
3. How health inequalities accumulate and combine to affect treatment value: A distributional cost-effectiveness analysis of smoking cessation interventions.
Love-Koh J; Pennington B; Owen L; Taylor M; Griffin S
Soc Sci Med; 2020 Nov; 265():113339. PubMed ID: 33039733
[TBL] [Abstract][Full Text] [Related]
4. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
5. Distributional Cost-Effectiveness Analysis of Treatments for Non-Small Cell Lung Cancer: An Illustration of an Aggregate Analysis and its Key Drivers.
Meunier A; Longworth L; Gomes M; Ramagopalan S; Garrison LP; Popat S
Pharmacoeconomics; 2023 Aug; 41(8):1011-1025. PubMed ID: 37296369
[TBL] [Abstract][Full Text] [Related]
6. The Health Inequality Impact of Liquid Biopsy to Inform First-Line Treatment of Advanced Non-Small Cell Lung Cancer: A Distributional Cost-Effectiveness Analysis.
Jansen JP; Ragavan MV; Chen C; Douglas MP; Phillips KA
Value Health; 2023 Dec; 26(12):1697-1710. PubMed ID: 37741446
[TBL] [Abstract][Full Text] [Related]
7. Equity and economic evaluation of system-level health interventions: A case study of Brazil's Family Health Program.
Love-Koh J; Mirelman A; Suhrcke M
Health Policy Plan; 2021 Apr; 36(3):229-238. PubMed ID: 33386400
[TBL] [Abstract][Full Text] [Related]
8. Explicit incorporation of equity considerations into economic evaluation of public health interventions.
Cookson R; Drummond M; Weatherly H
Health Econ Policy Law; 2009 Apr; 4(Pt 2):231-45. PubMed ID: 19216834
[TBL] [Abstract][Full Text] [Related]
9. Uncertainty Analysis in Intervention Impact on Health Inequality for Resource Allocation Decisions.
Yang F; Duarte A; Walker S; Griffin S
Med Decis Making; 2021 Aug; 41(6):653-666. PubMed ID: 34098791
[TBL] [Abstract][Full Text] [Related]
10. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
[TBL] [Abstract][Full Text] [Related]
11. A pharmacoeconomic approach to assessing the costs and benefits of air quality interventions that improve health: a case study.
Lomas J; Schmitt L; Jones S; McGeorge M; Bates E; Holland M; Cooper D; Crowther R; Ashmore M; Rojas-Rueda D; Weatherly H; Richardson G; Bojke L
BMJ Open; 2016 Jun; 6(6):e010686. PubMed ID: 27329439
[TBL] [Abstract][Full Text] [Related]
12. Using a survey to estimate health expectancy and quality-adjusted life expectancy to assess inequalities in health and quality of life.
Collins B
Value Health; 2013 Jun; 16(4):599-603. PubMed ID: 23796294
[TBL] [Abstract][Full Text] [Related]
13. Distributional cost effectiveness analysis of West Yorkshire low emission zone policies.
Griffin S; Walker S; Sculpher M
Health Econ; 2020 May; 29(5):567-579. PubMed ID: 32003147
[TBL] [Abstract][Full Text] [Related]
14. Ixekizumab for Treating Moderate-to-Severe Plaque Psoriasis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.
Ramaekers BLT; Wolff RF; Pouwels X; Oosterhoff M; Van Giessen A; Worthy G; Noake C; Armstrong N; Kleijnen J; Joore MA
Pharmacoeconomics; 2018 Aug; 36(8):917-927. PubMed ID: 29480455
[TBL] [Abstract][Full Text] [Related]
15. Precision QALYs, Precisely Unjust.
Fleck LM
Camb Q Healthc Ethics; 2019 Jul; 28(3):439-449. PubMed ID: 31298190
[TBL] [Abstract][Full Text] [Related]
16. The Impact of Funding Inpatient Treatments for COVID-19 on Health Equity in the United States: A Distributional Cost-Effectiveness Analysis.
Kowal S; Ng CD; Schuldt R; Sheinson D; Cookson R
Value Health; 2023 Feb; 26(2):216-225. PubMed ID: 36192293
[TBL] [Abstract][Full Text] [Related]
17. Distributional impact of the Malawian Essential Health Package.
Arnold M; Nkhoma D; Griffin S
Health Policy Plan; 2020 Jul; 35(6):646-656. PubMed ID: 32361730
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]